EGRX Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology.

$47.41  -1.19 (-2.45%)
As of 12/03/2021 15:59:53 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2014
Outstanding shares:  12,913,879
Average volume:  72,252
Market cap:   $627,614,519
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    269796108
ISIN:        US2697961082
Sedol:      BJH7VB4
Valuation   (See tab for details)
PE ratio:   108.85
PB ratio:   3.31
PS ratio:   3.50
Return on equity:   3.04%
Net income %:   3.14%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy